Last updated Nov 1, 2017
A board of directors, accountable to the members of the company (the Medical Research Council and The Wellcome Trust), act as company directors and as charity trustees. They have overall responsibility for the direction, management and control of UK Biobank Limited. The Board is chaired by Sir Mike Rawlins.
Sir Michael Rawlins
Professor Martin Bobrow, Emeritus Fellow, Wolfson College Cambridge
Ruth Gilbert, Professor of Clinical Epidemiology, UCL
Andrew Hattersley, Professor of Molecular Medicine, University of Exeter Medical School
Sir Alex Markham, Professor of Medicine, University of Leeds
Dr Sara Marshall, Head of Clinical Research, Wellcome Trust
Dr Joe McNamara, Head of Population Health Sciences, MRC
Bill Ollier, Professor of Immunogenetics, Manchester University
Mr Jonathan Tross CB
Dr Patrick Vallance, President, R&D, GSK
Mr Jonathan Sellors is Board Secretary.